Announcement

6
DECEMBER
2019


Category Label


Client Announcements

Chamberlin PLC : Contract award for Scunthorpe foundry

  •  
  •   06 December 2019

RNS Number : 8839V

Chamberlin PLC

06 December 2019

 

AIM: CMH

6 December 2019

 

 

CHAMBERLIN PLC

("Chamberlin" or the "Company")

 

 

Contract award for Scunthorpe foundry

 

Chamberlin, the specialist castings and engineering group, is pleased to announce the award of a significant new order for Russell Ductile Castings Limited, Chamberlin's iron and steel casting foundry based in Scunthorpe.  The new order is for the supply of flap valves for the construction of the Thames Tideway Tunnel.

 

The initial order is for £0.9 million and represents approximately 50% of the total value of the contract which is worth up to £1.8 million.  Production of the valves will commence in the current financial year, although the full benefit of the order will be seen through 2020 and beyond.

 

 

Kevin Nolan, Chief Executive of Chamberlin commented:

 

"In securing this very material order it is pleasing to note that Russell Ductile Castings is one of only a few foundries based in the UK capable of producing the cross section of complex castings required for this project. This order will go a long way towards securing production at the Scunthorpe facility for the foreseeable future".

 

 

 

Enquiries

 

Chamberlin plc

Kevin Nolan, Chief Executive

Neil Davies, Finance Director

 

T: 01922 707100

 

 

 

 

Cenkos Securities plc (Nominated Adviser and Broker)

Russell Cook

Katy Birkin

 

T: 020 7397 8900

 

 

 

KTZ Communications (Financial PR)

Katie Tzouliadis

Dan Mahoney

 

T: 020 3178 6378

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTFSWFMIFUSESE

;